The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Severe pulmonary disease associated with electronic-cigarette–product use—interim Guidance
Open accessAbstract
On September 6, 2019, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). As of August 27, 2019, 215 possible cases of severe pulmonary disease associated with the use of electronic cigarette (e-cigarette) products (e.g., devices, liquids, refill pods, and cartridges) had been reported to CDC by 25 state health departments. E-cigarettes are devices that produce an aerosol by heating a liquid containing various chemicals, including nicotine, flavorings, and other additives (e.g., propellants, solvents, and oils). Users inhale the aerosol, including any additives, into their lungs. Aerosols produced by e-cigarettes can contain harmful or potentially harmful substances, including heavy metals such as lead, volatile organic compounds, ultrafine particles, cancer-causing chemicals, or other agents such as chemicals used for cleaning the device (1). E-cigarettes also can be used to deliver tetrahydrocannabinol (THC), the principal psychoactive component of cannabis, or other drugs; for example, "dabbing" involves superheating substances that contain high concentrations of THC and other plant compounds (e.g., cannabidiol) with the intent of inhaling the aerosol. E-cigarette users could potentially add other substances to the devices. This report summarizes available information and provides interim case definitions and guidance for reporting possible cases of severe pulmonary disease. The guidance in this report reflects data available as of September 6, 2019; guidance will be updated as additional information becomes available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adverse health effects in humans have also been documented, linking e-cigarette use with increased risk of lung injury.16–19”
From Adverse Birth Outcomes Associated With Prepregnancy and Prenatal Electronic Cigarette Use (2021) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Public Health Consequences of E-Cigarettes
Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems, Board on Population Health and Public Health Practice, Division, H. A. M., & National Academies of Sciences, E. (2018) · National Academies Press eBooks · doi:10.17226/24952 · Cited by 1,546
Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin—Final Report
Layden, J. E., Ghinai, I., Pray, I., Kimball, A., Layer, M., Tenforde, M. W., Navon, L., Hoots, B., Salvatore, P. P., Elderbrook, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911614 · Cited by 911 · cited 7×
“CDC staff members have deployed to Illinois and Wisconsin, the first states that identified patients, as part of an epidemiologic assistance investigation to assist with their state investigations and continue to work closely with affected states to characterize the * Outbreak surveillance case definitions are intende…”
BackgroundInfluentialSelf-citationPulmonary Lipid-Laden Macrophages and Vaping
Maddock, S. D., Cirulis, M. M., Callahan, S. J., Keenan, L. M., Pirozzi, C. S., Raman, S. M., & Aberegg, S. K. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1912038 · Cited by 223
Imaging of Vaping-Associated Lung Disease
Henry, T. S., Kanne, J. P., & Kligerman, S. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1911995 · Cited by 210
Davidson, K., Brancato, A., Heetderks, P., Mansour, W., Matheis, E., Nario, M., Rajagopalan, S., Underhill, B., Wininger, J., & Fox, D. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6836e1 · Cited by 186
Inhalation Toxicology of Vaping Products and Implications for Pulmonary Health
Traboulsi, H., Cherian, M. M., Rjeili, M. A., Preteroti, M., Bourbeau, J., Smith, B. M., Eidelman, D. H., & Baglole, C. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103495 · Cited by 171
Tzortzi, A., Kapetanstrataki, M., Evangelopoulou, V., & BEHRAKIS, P. K. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17072248 · Cited by 150
Deliwala, S. S., Sundus, S., Haykal, T., Theophilus, N., & Bachuwa, G. I. (2020) · Cureus · doi:10.7759/cureus.7513 · Cited by 17
Vaping induced pneumonitis: a small community hospital’s case series and analysis
Silverman, A. L., Siddique, H., Kumar, V., Le, T.-H., & Ng, J. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-1158-2 · Cited by 8
Patterson, C. M., Valchanov, K. P., Barker, A. P., Goddard, M. J., Yang, H., & Butchart, A. G. (2020) · ERJ Open Research · doi:10.1183/23120541.00013-2020 · Cited by 8
Cited by
What are the respiratory effects of e-cigarettes?
Gotts, J. E., Jordt, S.-E., McConnell, R., & Tarran, R. (2019) · BMJ · doi:10.1136/bmj.l5275 · Cited by 516
Siegel, D. A., Jatlaoui, T. C., Koumans, E. H., Kiernan, E. A., Layer, M., Cates, J. E., Kimball, A., Weissman, D. N., Petersen, E. E., Reagan-Steiner, S., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6841e3 · Cited by 265
Self-citationAdverse Birth Outcomes Associated With Prepregnancy and Prenatal Electronic Cigarette Use
Regan, A. K., Bombard, J. M., O’Hegarty, M. M., Smith, R. A., & Tong, V. T. (2021) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004432 · Cited by 74
Lessons from the public health responses to the US outbreak of vaping‐related lung injury
Hall, W., Gartner, C., & Bonevski, B. (2021) · Addiction · doi:10.1111/add.15108 · Cited by 66
Regan, A. K., & Pereira, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-92930-5 · Cited by 43
Metadata
- Authors
- Schier, J. G., Meiman, J. G., Layden, J., Mikosz, C. A., VanFrank, B., King, B. A., Salvatore, P. P., Weissman, D. N., Thomas, J., Melstrom, P. C., Baldwin, G. T., Parker, E. M., Courtney-Long, E. A., Krishnasamy, V. P., Pickens, C. M., Evans, M. E., Tsay, S. V., Powell, K. M., Kiernan, E. A., Marynak, K. L., Adjemian, J., Holton, K., Armour, B. S., England, L. J., Briss, P. A., Houry, D., Hacker, K. A., Reagan-Steiner, S., Zaki, S., Meaney-Delman, D., & CDC 2019 Lung Injury Response Group
- Affiliations
- Centers for Disease Control and Prevention (US)
- Wisconsin Department of Health Services (US)
- Illinois Department of Public Health (US)
- National Institute for Occupational Safety and Health (US)
- National Center for Environmental Health (US)
- Agency for Toxic Substances and Disease Registry (US)
- Corresponding author
- Schier, Joshua G.
- ORCID
- Meiman, Jonathan G.
- Layden, Jennifer
- Mikosz, Christina A.
- VanFrank, Brenna
- King, Brian A
- Salvatore, Phillip P.
- Weissman, David N.
- Melstrom, Paul C.
- Baldwin, Grant T.
- Parker, Erin M.
- Krishnasamy, Vikram P.
- Pickens, Cassandra M.
- Evans, Mary E.
- Tsay, Sharon V.
- Powell, Krista M.
- Kiernan, Emily A.
- Marynak, Kristy L.
- Adjemian, Jennifer
- Holton, Kelly
- England, Lucinda J.
- Houry, Debra
- Hacker, Karen A.
- Reagan-Steiner, Sarah
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2019-09-13
- Volume
- 68
- Issue
- 36
- Pages
- 787-790
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- PMC
- PMC6755818
- OpenAlex
- W2972027227
- Cited by
- 246
- References
- 10
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 26 · 2023: 23 · 2022: 24 · 2021: 35 · 2020: 96 · 2019: 23
- FWCI
- 30.41
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- electronic cigarettes, e-cigarette flavors, vaping-associated lung injury, case definition, tetrahydrocannabinol, dabbing, nicotine
- MeSH terms
- Vaping, Centers for Disease Control and Prevention, U.S., Humans, Lung Diseases, Severity of Illness Index, United States, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Severe pulmonary disease associated with electronic-cigarette–product use—interim Guidance. https://app.cochat.ai/papers/10.15585/mmwr.mm6836e2
- The paper
- Schier, J. G., Meiman, J. G., Layden, J., Mikosz, C. A., VanFrank, B., King, B. A., Salvatore, P. P., Weissman, D. N., Thomas, J., Melstrom, P. C., Baldwin, G. T., Parker, E. M., Courtney-Long, E. A., Krishnasamy, V. P., Pickens, C. M., Evans, M. E., Tsay, S. V., Powell, K. M., Kiernan, E. A., . . . CDC 2019 Lung Injury Response Group. (2019). Severe pulmonary disease associated with electronic-cigarette–product use—interim Guidance. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm6836e2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.